172 related articles for article (PubMed ID: 23986182)
1. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds.
Granchi C; Calvaresi EC; Tuccinardi T; Paterni I; Macchia M; Martinelli A; Hergenrother PJ; Minutolo F
Org Biomol Chem; 2013 Oct; 11(38):6588-96. PubMed ID: 23986182
[TBL] [Abstract][Full Text] [Related]
2. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
[TBL] [Abstract][Full Text] [Related]
3. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents.
D'Andrea F; Vagelli G; Granchi C; Guazzelli L; Tuccinardi T; Poli G; Iacopini D; Minutolo F; Di Bussolo V
Molecules; 2019 Sep; 24(19):. PubMed ID: 31569409
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5.
Granchi C; Roy S; Mottinelli M; Nardini E; Campinoti F; Tuccinardi T; Lanza M; Betti L; Giannaccini G; Lucacchini A; Martinelli A; Macchia M; Minutolo F
Bioorg Med Chem Lett; 2011 Dec; 21(24):7331-6. PubMed ID: 22056743
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Chen CY; Feng Y; Chen JY; Deng H
Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
[TBL] [Abstract][Full Text] [Related]
8. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
9. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.
Rupiani S; Buonfiglio R; Manerba M; Di Ianni L; Vettraino M; Giacomini E; Masetti M; Falchi F; Di Stefano G; Roberti M; Recanatini M
Eur J Med Chem; 2015 Aug; 101():63-70. PubMed ID: 26114812
[TBL] [Abstract][Full Text] [Related]
11. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
[TBL] [Abstract][Full Text] [Related]
12. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.
Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C
Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.
Granchi C; Fortunato S; Meini S; Rizzolio F; Caligiuri I; Tuccinardi T; Lee HY; Hergenrother PJ; Minutolo F
J Agric Food Chem; 2017 Jul; 65(28):5639-5649. PubMed ID: 28643510
[TBL] [Abstract][Full Text] [Related]
14. Synthetic methodology-enabled discovery of a tunable indole template for COX-1 inhibition and anti-cancer activity.
Guerra Faura G; Wu B; Oyelere AK; France S
Bioorg Med Chem; 2022 Mar; 57():116633. PubMed ID: 35134642
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, structure-activity relationships study and X-ray crystallography of 3-substituted-indolin-2-one-5-carboxamide derivatives as PAK4 inhibitors.
Guo J; Zhao F; Yin W; Zhu M; Hao C; Pang Y; Wu T; Wang J; Zhao D; Li H; Cheng M
Eur J Med Chem; 2018 Jul; 155():197-209. PubMed ID: 29886323
[TBL] [Abstract][Full Text] [Related]
16. Identification of the first highly selective inhibitor of human lactate dehydrogenase B.
Shibata S; Sogabe S; Miwa M; Fujimoto T; Takakura N; Naotsuka A; Kitamura S; Kawamoto T; Soga T
Sci Rep; 2021 Nov; 11(1):21353. PubMed ID: 34725423
[TBL] [Abstract][Full Text] [Related]
17. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
[TBL] [Abstract][Full Text] [Related]
18. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
20. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
